Journal article
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
Abstract
Background BRCA1 and BRCA2 (BRCA) mutation carriers face a high lifetime risk of developing ovarian cancer. Oral contraceptives are protective in this population; however, the impact of other types of contraception (e.g. intrauterine devices, implants, injections) is unknown. We undertook a matched case-control study to evaluate the relationship between type of contraception and risk of ovarian cancer among women with BRCA mutations. Methods A …
Authors
Xia YY; Gronwald J; Karlan B; Lubinski J; McCuaig JM; Brooks J; Moller P; Eisen A; Sun S; Senter L
Journal
Gynecologic Oncology, Vol. 164, No. 3, pp. 514–521
Publisher
Elsevier
Publication Date
March 2022
DOI
10.1016/j.ygyno.2022.01.014
ISSN
0090-8258